TPH Earnings

TPH reported its earnings on 2026-02-25, showcasing a revenue of against an estimate of 908.70M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.78 by 0%. The stock experienced a 0.02% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following TPH's earnings announcement on 2026-02-25, the stock price moved by 0.02% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, TPH's stock price tends to shift by an average of -1.02% in the 10 days leading up to earnings and 0.72% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate TPH's annual revenue to reach 625.50M, while the EPS is projected at 0.20. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between TPH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, TPH's stock price typically moves by -1.02% in the 10 days before its earnings and 0.72% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.20 and revenue of 625.50M.

The earnings call presents a mixed outlook. Strong financial metrics and land investments indicate potential growth, but weak guidance and market challenges temper expectations. The Q&A reveals concerns about incentives and spec inventory, with management providing some positive insights on margins and community growth. The neutral sentiment reflects balanced positives and negatives, with no strong catalysts for significant stock price movement. Given the company's mid-sized market cap, the stock is likely to remain stable, resulting in a neutral prediction of -2% to 2% over the next two weeks.